COMP <GO>
CLX vs MA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Clorox Company (The) (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: CLX 7
— MA 8
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MA
LAST: $88.00 (-0.76%) • MKT CAP: $10.72B
options-implied-move
6.70%
LAST: $638.01 (+0.36%) • MKT CAP: $556.88B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLX | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.20% | 41.00% | +4.20 | CLX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.20% | 33.50% | +3.70 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 29.2x | -18.30 | CLX | /valuation <GO> |
| Free Cash Flow Yield | 7.10% | 3.08% | +4.02 | CLX | /fcf-yield <GO> |
| Operating Margin | 14.20% | 57.60% | -43.40 | MA | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 45.60% | -34.00 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | 0.20% | 16.40% | -16.20 | MA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.61% | 0.49% | +5.12 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 11.17 | -8.24 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 6.60% | +0.10 | MA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 70.6 | -16.80 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.90 | +0.03 | CLX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.1x | 31.2x | -19.10 | CLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.72B | $556.88B | -$546.16B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLX REV | MA REV | CLX GROSS % | MA GROSS % | CLX FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.10B | $32.79B | 45.2% | 44.0% | $761.0M | $17.16B |
| FY 2024 | $7.09B | $28.17B | 43.0% | 44.0% | $483.0M | $14.31B |
| FY 2023 | $7.39B | $25.10B | 44.0% | 44.0% | $825.5M | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLX // BETA 0.93
MA // BETA 0.90